Efficacy of Different Treatments for the Intensive Care Unit Acquired Weakness

NCT ID: NCT04613908

Last Updated: 2020-11-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-08-01

Study Completion Date

2016-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Experimental study that has how to compare the efficacy between conventional rehabilitation, transcutaneous electrostimulation or early mobilization to reduce the time needed to reverse the muscle weakness evaluated by the muscle strength scale of the MRC in patients with a clinical diagnosis of intensive care unit acquired weakness in the (ICUAW).The ambit of realization is a medical-surgical ICU of a general acute hospital (26 beds). A randomized controlled, uni-centric design was used. The interventions are divided into three groups namely; group 1 (control group) receiving standard or usual rehabilitation (GR-STD); group 2 receives transcutaneous electrostimulation (GR-TEE) and group 3 that consists of an early mobilization protocol (GR-EM). The main outcome variable of the study is the time, in days and sessions of treatment, to reverse the ICUAW.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study hypothesis: the time to revert the intensive care unit acquired weakness is less when applying an early mobilization protocol or transcutaneous electro-nervous stimulation compared with the usual or standard rehabilitative treatment.

Ethical considerations: The research protocol was presented and approved by both the Ethics Committee and the Teaching and Research Committee of our institution. The informed consent of each subject included in the study was obtained.

Sample size and study power: a sample size was defined in 18 subjects (6 subjects per intervention group). The estimation of the sample was calculated for a one-way ANOVA where a minimum difference of 2 sessions was established between the treatments, assuming a standard deviation of 1.8 sessions, an alpha error of 5% and a power of 80%.

Statistical methods: the numerical variables will be presented as mean and standard deviation or median and interquartile range according to the presented distribution. The categorical variables will be presented by frequency and percentage.

For the comparison of continuous variables, Student's t test for independent samples or the Mann-Whitney U test will be used according to the presented distribution and for the categorical variables the Chi² test or the Fisher exact test will be used according to the conformation of the crossed table. The Shapiro-Wilk test will be used to evaluate whether the distribution presented by the numerical variables fits a normal distribution. Equality of variances was assessed by the Levene´s test.

The comparison of the time to reach an smuscle strength scale of the MRC ≥ 48 between the groups with different interventions will be used the one-way ANOVA test or the Kruskal-Wallis test as appropriate. For post hoc analysis, the pairs-comparison test of Games-Hollew or Dunn's-Bonferroni will be used for ANOVA or Kruskal-Wallis, respectively, when they reach statistical significance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Muscle Weakness Rehabilitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

3 Groups Group 1 (GR-STD) received the standard or usual rehabilitation treatment used in our ICU as intervention.

Group 2 (GR-NMES) received neuro muscular electro stimulation sessions in addition to the standard treatment.

Group 3 (GR-EM) received an early mobilization protocol as intervention.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
the person in charge of performing the statistical analysis was blind, by coding the interventions in the database.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

standard care or usual rehabilitation

It will consist of the usual treatment performed by the intensive care physiotherapist, it will be applied every day that the study lasts.

Group Type ACTIVE_COMPARATOR

standard care or usual rehabilitation

Intervention Type OTHER

routine, non-protocolized rehabilitation treatment performed by the physiotherapist assigned to intensive care

neuro muscular electro stimulation

They received 5 sessions per week (except weekends) of neuromuscular electrostimulation of 30 minutes duration. Also, every day that the study is carried out in the morning and in the afternoon, the subjects will receive the usual treatment performed by the intensive care physiotherapist.

Group Type EXPERIMENTAL

neuro muscular electro stimulation

Intervention Type DEVICE

We used a commercial equipment of electro stimulation with a pulse width of 300 micro seconds, a frequency of 50 Hz, with symmetrical balanced biphasic rectangular wave and with an intensity of up to 80 milliampere.

early mobilization protocol

Throughout the duration of the study, an early mobilization protocol will be applied to apply a specific treatment based on different levels of treatment for each subject of the group; It differs from the usual procedure in protocolized progression according to the objectives reached by the patient, unlike the usual treatment, where the progression is in accordance with the clinical criteria of the treatment professional.

Group Type EXPERIMENTAL

Early Mobilization protocol

Intervention Type OTHER

The protocol consisted in applying a specific treatment based on different levels of treatment to each subject. Admission to them was carried out according to the maximum capacity of each subject, the conditions of each level being the following:

* Level 1: MRC (shoulder) \<3 + MRC \<3 (hip).
* Level 2: MRC (shoulder) ≥ 3 + MRC (hip) \<3.
* Level 3: MRC (shoulder) ≥ 3 + MRC (hip) ≥ 3 + sitting on the edge of the bed without assistance (minimum 15 minutes).
* Level 4: Standing without assistance and walking with or without assistance.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

neuro muscular electro stimulation

We used a commercial equipment of electro stimulation with a pulse width of 300 micro seconds, a frequency of 50 Hz, with symmetrical balanced biphasic rectangular wave and with an intensity of up to 80 milliampere.

Intervention Type DEVICE

Early Mobilization protocol

The protocol consisted in applying a specific treatment based on different levels of treatment to each subject. Admission to them was carried out according to the maximum capacity of each subject, the conditions of each level being the following:

* Level 1: MRC (shoulder) \<3 + MRC \<3 (hip).
* Level 2: MRC (shoulder) ≥ 3 + MRC (hip) \<3.
* Level 3: MRC (shoulder) ≥ 3 + MRC (hip) ≥ 3 + sitting on the edge of the bed without assistance (minimum 15 minutes).
* Level 4: Standing without assistance and walking with or without assistance.

Intervention Type OTHER

standard care or usual rehabilitation

routine, non-protocolized rehabilitation treatment performed by the physiotherapist assigned to intensive care

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

DEMAX® model Quatrum Duo

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* subjects over 18 years of age,
* admitted to the ICU who have received invasive mechanical ventilation for a period longer than 24 hours
* clinical diagnosis of ICUAW (MRC-mss \<48 measured over two consecutive days).

Exclusion Criteria

* subjects who presented a body mass index\> 35 (kg/height x height)
* presence of edema that prevents the realization of NMES at the time of diagnosis of ICUAW (assessed by the absence of visible contraction
* pregnant women
* subjects with pacemakers
* subjects with injury of the central and / or peripheral nervous system (with motor sequelae)
* previous neuromuscular disease
* limitation of the movement of any extremity due to orthopedic or traumatological causes
* presence of a previous cognitive disorder that impedes the understanding of rehabilitation interventions
* a value of the index of Barthel less than 35 points at admission
* subjets who refused to give informed consent.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Nacional Profesor Alejandro Posadas

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ladislao Diaz Ballve

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ladislao P Diaz Ballve

Role: PRINCIPAL_INVESTIGATOR

Hospital Nacional Posadas

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

02-2018

Identifier Type: -

Identifier Source: org_study_id